{"id":"W3118976699","doi":"10.1007/s10637-020-01043-9","title":"The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial","year":2021,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; Fondation du cancer des Cèdres; Frank McGraw Memorial Chair in Cancer Research","keywords":"Pembrolizumab; Ovary; Medicine; Clinical trial; Oncology; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008629074,0.0002673429,0.0009319999,0.0002993305,0.0004063091,0.0007529222,0.0002857936,0.0006727512,0.0005936488],"category_scores_gemma":[0.001771884,0.0001420603,0.0006968832,0.0004131542,0.0004484383,0.0005222209,0.0002052763,0.0007253889,0.0001708547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004714724,"about_ca_system_score_gemma":0.0003537761,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003235404,"about_ca_topic_score_gemma":0.0005502396,"domain_scores_codex":[0.9996021,0.000115814,0.00005702724,0.00006653529,0.00007414715,0.00008430442],"domain_scores_gemma":[0.9993472,0.0002935709,0.0001562132,0.00005813206,0.00003902556,0.0001058357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03276382,0.003694951,0.5708609,0.0008953284,0.001263349,0.084066,0.00100463,0.001575774,0.04845348,0.0007181313,0.003053975,0.2516496],"study_design_scores_gemma":[0.0114573,0.05402271,0.5550909,0.000333852,0.002759138,0.3386751,0.0008692924,0.005939198,0.01461933,0.00090133,0.01522109,0.000110816],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941765,0.003970549,0.0002883309,0.0001900444,0.0000153988,0.00009825057,0.0000967184,0.000005995896,0.001158096],"genre_scores_gemma":[0.9978076,0.001292872,0.0002358073,0.0001997329,0.00004574172,0.0000326134,0.0002536353,0.00000487553,0.0001270802],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009319999,"threshold_uncertainty_score":0.00456357,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02975482929178661,"score_gpt":0.2904753696380554,"score_spread":0.2607205403462688,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}